Deficiency of non-muscle myosin IIA promotes neuroinflammation by impairing autophagic degradation of VCAM-1 in brain endothelium
Abstract
Endothelial cell dysfunction is a major driver of neuroinflammation, a critical contributor to neurological disorders. Non-muscle myosin IIA (NMIIA), a key cytoskeletal protein, has been implicated in cerebrovascular pathology, but its role in endothelial-mediated neuroinflammation remains unclear. This study reveals that NMIIA expression is downregulated in brain microvascular endothelial cells during aging. Using in vitro knockdown and endothelial-specific conditional knockout mouse models, we demonstrate that NMIIA deficiency specifically upregulates VCAM-1 protein without affecting its mRNA or other inflammatory mediators. Mechanistically, NMIIA loss impairs autophagic flux, particularly the autophagosome-lysosome fusion, leading to inhibited autophagic degradation and subsequent accumulation of VCAM-1. Proteomic analysis and biochemical assays identified Caveolin-1 (Cav-1) as a direct binding partner of NMIIA. NMIIA deficiency promotes the redistribution of the autophagy-related protein ATG5 into Cav-1-enriched lipid raft domains, a process known to suppress autophagy initiation. Functionally, soluble VCAM-1 released from NMIIA-deficient endothelial cells promotes pro-inflammatory polarization of microglia and induces neuronal apoptosis in vitro. In vivo, NMIIA iECKO mice exhibit increased microglial activation, impaired hippocampal neurogenesis, neuronal loss, and significant deficits in learning and memory behaviors. Collectively, our findings define a novel NMIIA–Cav-1–autophagy–VCAM-1 regulatory axis in brain endothelium, positioning NMIIA as a crucial maintainer of neurovascular homeostasis by preventing VCAM-1-driven neuroinflammation. This pathway provides new mechanistic insights into aging-related cerebrovascular dysfunction and offers potential therapeutic targets for neuroinflammatory diseases.
Related
- Thymoquinone suppresses papillary thyroid carcinoma by impairing autophagic flux via the PDZK1IP1/HMGCS1 axis
- Ginsenoside Rb2 promotes p62-mediated LDHA autophagic degradation to inhibit H3K18la-dependent PD-L1 transcription in cervical cancer
- A multi-subunit autophagic capture complex facilitates degradation of ER-stalled MHC class I in pancreatic cancer
- ATG13 Recruits LC3 to Target H9N2-IAV PB1 for Autophagic-Lysosomal Degradation and Restricts Viral Replication
- Dose‐Dependent Autophagic Dysfunction and CCR5‐Mediated Neuroinflammation Drive Arsenic Trioxide‐Induced Cortical Neurodegeneration in Mice
BibTeX
@article{zhang2026deficiency,
title = {{Deficiency of non-muscle myosin IIA promotes neuroinflammation by impairing autophagic degradation of VCAM-1 in brain endothelium}},
author = {Haiyi Zhang and Yawei Li and Xinhong Zhao and Yujie Zhao and Jinchao Gu and Hao Pan and Aijun Liu and Jiangguo Lin and Yuanyuan Peng and Lijun Wang and Huantian Zhang and Jiahui Cao},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-75768-7},
url = {https://www.nature.com/articles/s41598-026-75768-7},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Deficiency of non-muscle myosin IIA promotes neuroinflammation by impairing autophagic degradation of VCAM-1 in brain endothelium
AU - Haiyi Zhang
AU - Yawei Li
AU - Xinhong Zhao
AU - Yujie Zhao
AU - Jinchao Gu
AU - Hao Pan
AU - Aijun Liu
AU - Jiangguo Lin
AU - Yuanyuan Peng
AU - Lijun Wang
AU - Huantian Zhang
AU - Jiahui Cao
PY - 2026
DA - 2026/10/24
JO - Scientific Reports
DO - 10.1038/s41598-026-75768-7
UR - https://www.nature.com/articles/s41598-026-75768-7
AB - Endothelial cell dysfunction is a major driver of neuroinflammation, a critical contributor to neurological disorders. Non-muscle myosin IIA (NMIIA), a key cytoskeletal protein, has been implicated in cerebrovascular pathology, but its role in endothelial-mediated neuroinflammation remains unclear. This study reveals that NMIIA expression is downregulated in brain microvascular endothelial cells during aging. Using in vitro knockdown and endothelial-specific conditional knockout mouse models, we demonstrate that NMIIA deficiency specifically upregulates VCAM-1 protein without affecting its mRNA or other inflammatory mediators. Mechanistically, NMIIA loss impairs autophagic flux, particularly the autophagosome-lysosome fusion, leading to inhibited autophagic degradation and subsequent accumulation of VCAM-1. Proteomic analysis and biochemical assays identified Caveolin-1 (Cav-1) as a direct binding partner of NMIIA. NMIIA deficiency promotes the redistribution of the autophagy-related protein ATG5 into Cav-1-enriched lipid raft domains, a process known to suppress autophagy initiation. Functionally, soluble VCAM-1 released from NMIIA-deficient endothelial cells promotes pro-inflammatory polarization of microglia and induces neuronal apoptosis in vitro. In vivo, NMIIA iECKO mice exhibit increased microglial activation, impaired hippocampal neurogenesis, neuronal loss, and significant deficits in learning and memory behaviors. Collectively, our findings define a novel NMIIA–Cav-1–autophagy–VCAM-1 regulatory axis in brain endothelium, positioning NMIIA as a crucial maintainer of neurovascular homeostasis by preventing VCAM-1-driven neuroinflammation. This pathway provides new mechanistic insights into aging-related cerebrovascular dysfunction and offers potential therapeutic targets for neuroinflammatory diseases.
SN - 2045-2322
ER -